If it's not a shrine, it's them immortalizing the label or logo as body tattoos ... helping bring in multinational giants like Cadbury, Boehringer Ingelheim and Samsung before heading up marketing ...

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...

No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...

People with chronic kidney disease, Type 2 diabetes or both were predicted to have elevated cardiovascular disease (CVD) risk 8 to 28 years sooner than someone without those conditions, according to a ...

U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...

Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers ...

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...

Nearly 60 employees at Ridgefield biopharma firm Boehringer Ingelheim have taken part in the same program known as "A Life in a Day," and say it has changed how they do their jobs. “ ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...